In Figures 8(c)–8(f), peptide ARHGEF9 suppressed the proliferation and migration of glioma cells, while IGF-1 could weaken the effect of peptide ARHGEF9 on the proliferation and migration of glioma cells. The gene discussed is IGF1; the disease is central nervous system cancer.